Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Bacterial Biopolymers

Fedrick Tyler

A vast range of extracellular and intracellular biopolymers, including polyamides, polysaccharides, polyphosphates, polyesters, proteinaceous compounds, and extracellular DNA, may be produced by bacteria, which are regarded as the primary cell manufacturers. Bacterial biopolymers are employed in pathogenicity and are appropriate for use in the pharmaceutical industry due to their wide range of physical and chemical characteristics. When these biopolymer compounds are created by non-pathogenic bacteria, they function as food additives or biomaterials, however when they are derived from pathogenic bacteria, they serve as significant virulence factors. Using synthetic biology to create novel biomaterials, there have been multidisciplinary researches looking at the molecular processes involved in the synthesis of bacterial biopolymers and the discovery of new antimicrobial drug targets.